Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Retroviral Agents”

1,940 trials

Showing 20 of 1,940 results

Testing effectiveness (Phase 2)Ended earlyNCT00102778
What this trial is testing

GW873140 In Combination With Kaletra In HIV Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 175
Not applicableStudy completedNCT03978793
What this trial is testing

MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users

Who this might be right for
HIV-positive Individuals
Ohio State University 31
Not applicableStudy completedNCT02128087
What this trial is testing

Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders

Who this might be right for
Human Immunodeficiency Virus
RAND 330
Early research (Phase 1)Study completedNCT00879047
What this trial is testing

Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection

Who this might be right for
HIV InfectionsHepatitis C
University of California, San Francisco 30
Not applicableStudy completedNCT00602758
What this trial is testing

Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV

Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
University of Missouri, Kansas City 252
Not applicableStudy completedNCT02363387
What this trial is testing

Suppression of HIV 1 RNA in People Living With HIV

Who this might be right for
HIV
Johns Hopkins University 102
Not applicableStudy completedNCT02206906
What this trial is testing

Incentives to Promote Medication Adherence Among HIV-Infected Youth

Who this might be right for
HIV
St. Jude Children's Research Hospital 25
Not applicableWithdrawnNCT01394133
What this trial is testing

Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in HIV-Infected Women

Who this might be right for
HIV Infected
University of Alabama at Birmingham
Large-scale testing (Phase 3)Study completedNCT00002244
What this trial is testing

Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease

Who this might be right for
HIV Infections
OXO Chemie 240
Early research (Phase 1)Study completedNCT00326716
What this trial is testing

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

Who this might be right for
HIV Infection
Bristol-Myers Squibb 69
Not applicableStudy completedNCT04333498
What this trial is testing

Use of Antiretroviral (ARV) Drug Levels in Dried Blood Spots (DBS) to Assess and Manage ART Adherence in South Africa

Who this might be right for
Therapeutic Adherence and Compliance
New York State Psychiatric Institute 60
Not applicableStudy completedNCT02515149
What this trial is testing

Impact on Linkage to HIV Care With Point of Care CD4 Testing and Home-based HIV Testing in Kenya

Who this might be right for
HIV
Centers for Disease Control and Prevention 770
Testing effectiveness (Phase 2)Study completedNCT00004584
What this trial is testing

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Large-scale testing (Phase 3)UnknownNCT04500678
What this trial is testing

Impact of Metformin on Immuno-virologic Parameters in HIV

Who this might be right for
HIV/AIDS
University of Hawaii 38
Large-scale testing (Phase 3)Study completedNCT04223778
What this trial is testing

Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 672
Early research (Phase 1)Study completedNCT00000810
What this trial is testing

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Testing effectiveness (Phase 2)Looking for participantsNCT04648280
What this trial is testing

Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

Who this might be right for
HIV Infections With Multi Drug Resistant Virus
PENTA Foundation 60
Testing effectiveness (Phase 2)Study completedNCT00000940
What this trial is testing

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 121
Early research (Phase 1)Ended earlyNCT07115368
What this trial is testing

Study of GS-1219 in Participants With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 4
Testing effectiveness (Phase 2)Study completedNCT00076518
What this trial is testing

The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV InfectionsHypertriglyceridemia
National Institute of Allergy and Infectious Diseases (NIAID) 100
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation